Point72 Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,722,984
Closed -$69.2M 1424
2025
Q1
$69.2M Buy
1,722,984
+1,553,071
+914% +$62.4M 0.16% 149
2024
Q4
$7.99M Sell
169,913
-294,097
-63% -$13.8M 0.02% 581
2024
Q3
$24.5M Buy
464,010
+89,162
+24% +$4.71M 0.06% 315
2024
Q2
$20.3M Buy
374,848
+10,139
+3% +$549K 0.05% 356
2024
Q1
$25.6M Buy
364,709
+207,609
+132% +$14.6M 0.06% 338
2023
Q4
$13.1M Buy
+157,100
New +$13.1M 0.03% 508
2023
Q3
Sell
-160,400
Closed -$5.23M 1837
2023
Q2
$5.23M Buy
+160,400
New +$5.23M 0.02% 666
2023
Q1
Sell
-271,500
Closed -$12.4M 1742
2022
Q4
$12.4M Buy
271,500
+239,500
+748% +$11M 0.04% 448
2022
Q3
$1.55M Buy
32,000
+12,367
+63% +$599K 0.01% 799
2022
Q2
$771K Sell
19,633
-1,602,967
-99% -$62.9M ﹤0.01% 877
2022
Q1
$59.7M Buy
1,622,600
+737,146
+83% +$27.1M 0.24% 108
2021
Q4
$40.4M Sell
885,454
-123,846
-12% -$5.64M 0.16% 166
2021
Q3
$36.1M Buy
1,009,300
+681,800
+208% +$24.4M 0.16% 153
2021
Q2
$6.48M Sell
327,500
-47,100
-13% -$932K 0.03% 512
2021
Q1
$8.71M Sell
374,600
-791,694
-68% -$18.4M 0.04% 436
2020
Q4
$24.2M Sell
1,166,294
-440,056
-27% -$9.14M 0.12% 229
2020
Q3
$34.8M Buy
1,606,350
+1,278,073
+389% +$27.7M 0.18% 145
2020
Q2
$7.74M Sell
328,277
-462,923
-59% -$10.9M 0.05% 374
2020
Q1
$9.33M Sell
791,200
-2,237,551
-74% -$26.4M 0.08% 302
2019
Q4
$32.1M Buy
3,028,751
+2,594,651
+598% +$27.5M 0.17% 169
2019
Q3
$4.94M Sell
434,100
-172,900
-28% -$1.97M 0.03% 428
2019
Q2
$6.83M Buy
+607,000
New +$6.83M 0.04% 391